Recall Alert: Blood Pressure Medication Pulled After Possible Drug Contamination
A widely used high blood pressure medication is being recalled after testing revealed possible contamination with another drug. The FDA announced that certain bottles of bisoprolol fumarate and hydrochlorothiazide tablets — sold under the brand name Ziac — may contain traces of ezetimibe, a cholesterol drug produced by the same manufacturer.
The tablets, dosed between 2.5 mg and 6.25 mg, were made in Madhya Pradesh, India, for Glenmark Pharmaceuticals. More than 11,100 bottles have been recalled, according to The Hill. Testing of reserve samples detected ezetimibe in multiple lots, prompting the company to voluntarily remove the affected medication from circulation.
The recall includes three bottle sizes:
• 30-count, NDC 68462-878-30, Lot 17232401 (exp. 11/2025)
• 100-count, NDC 68462-878-01, Lot 17232401 (exp. 11/2025)
• 500-count, NDC 68462-878-05, Lots 17232401 (exp. 11/2025) and 17240974 (exp. 05/2026)
The FDA classified the recall as Class III, meaning the issue is unlikely to cause adverse health consequences. However, patients who rely on Ziac for blood pressure control should still verify their medication and contact their pharmacy or doctor if they suspect their bottle is part of the recall.
Ziac combines two drugs: bisoprolol, a beta blocker that helps the heart maintain a normal rhythm, and hydrochlorothiazide, a diuretic that removes excess sodium and water. Together, they help lower blood pressure and reduce the risk of heart attacks and strokes.
Patients are advised not to stop taking prescribed medication without consulting a healthcare provider, but they should seek guidance if they believe they have an affected lot.